Sushil K Rijhwani

Title: Sushil K Rijhwani: Innovator in Antiviral Agent Development

Introduction

Sushil K Rijhwani is a notable inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of antiviral agents, particularly through his innovative processes for preparing entecavir. With a total of 2 patents, Rijhwani's work is recognized for its impact on pharmaceutical development.

Latest Patents

Rijhwani's latest patents include processes for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-3-methylenecyclopentyl]-6H-purin-6-one. These processes disclose methods for the isolation and purification of entecavir, along with various intermediates useful in its preparation. Another patent focuses on a similar antiviral agent, showcasing Rijhwani's expertise in this critical area of research.

Career Highlights

Sushil K Rijhwani is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in antiviral agents. His work has contributed to the development of effective treatments that can combat viral infections, demonstrating his commitment to improving public health.

Collaborations

Rijhwani has collaborated with notable colleagues such as Yeung Yu Chan and Yadagiri R Pendri. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes in the pharmaceutical industry.

Conclusion

Sushil K Rijhwani is a distinguished inventor whose work in antiviral agent development has made a significant impact on the pharmaceutical field. His innovative processes and collaborations continue to drive advancements in healthcare.